1SABATINE M S, MORROW D A, DE LEMOS J A, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia[J]. J Am Coll Cardiol, 2004, 44 (10): 1988-1995.
2MARUMOTO K, HAMADA M, HIWADA K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris[J]. Clin Sci (Colch), 1995, 88(5) : 551-556.
3SAHINARSLAN A, CENGEL A, OKYAY K, et al. B- type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease[J]. Coron Artery Dis, 2005, 16 (4): 225-229.
4SCHNABEL R, LUBOS E, RUPPRECHT H J, et al. B- type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the athero gene study [J]. J Am Coll C ardiol, 2006, 47 (3): 552- 558.
5OMLAND T, SABATINE M S, JABLONSKI K A, et al. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE trial [ J ]. J Am Coll Cardiol, 2007, 50 (3): 205-214.
6FOOTE R S, PEARLMAN J D, SIEGEL A H, et al. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides[J]. J Am Coll Cardiol, 2004, 44(10) : 1980-1987.
7ZAID G, TANCHILEVITCH A, RIVLIN E, et al. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with Spect perfusionimaging[J]. Int J Cardiol, 2007, 117 (2): 157-164.
8MUELLER C. The Use of B-Type natriuretic peptides in coronary artery disease: utile or futile[J]? J Am Coil Cardiol, 2007, 50 (3): 215-216.
9KIM B S, LEE H J, SHIN H S, et al. Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function[J]. Transl Res, 2006, 148 (4): 188-195.
10WIVIOTT S D, DE LEMOS J A, MORROW D A. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes[J]. Clin ChimActa, 2004, 346 (2): 119-128.
二级参考文献31
1Katayama T, Nakashima H, Yonekura T, Honda Y, Suzuki S, Yano K. Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty. J Cardiol, 2003, 42: 195-200.
3Rabbani LE. Acute coronary syndromes-beyond myocyte necrosis. N Engl J Med,2001,345:1057-1059.
4Clerico A, Iervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans. Horm Metab Res,1999,31:487-498.
5Mair J, Friedl W, Thomas S, et al. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl,1999,230:132-142.
6Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci (Lond),1998,95:519-529.
7Maewal P, de Lemos JA. Natriuretic peptide hormone measurement in acute coronary syndromes. Heart Fail Rev,2003,8:365-368.
8Nagaya N, Nishikimi T, Goto Y, et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J,1998,135:21-28.
9Berger R. Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation,2002,105:2392-2397.
10Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol,2002, 89:463-465.
